Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Ets transcription factors and targets in osteogenesis

Oncogene volume 19, pages 6455–6463 (2000)Cite this article

Abstract

Bone formation in vivo is a complex phenomenon whereby recruitment and replication of mesenchymal precursors of osteoblasts, differentiation into preosteoblasts, osteoblasts, and mature osteoblasts ultimately result in the accumulation and mineralization of the extracellular matrix. MC3T3-E1, a clonal osteoblastic cell line, was derived from mouse calvaria and undergoes an ordered and time dependent developmental sequence leading to formation of multilayered bone nodules over a 30–35 day period. This developmental pattern is characterized by the replication of preosteoblasts followed by growth arrest and expression of mature osteoblastic characteristics such as matrix maturation and eventual formation of multilayered nodules with a mineralized extracellular matrix. We have found that Ets1 is expressed in proliferating preosteoblastic cells whereas Ets2 is expressed by differentiating and mature osteoblasts. In addition, the expression of Ets1 can be induced in MC3T3-E1 and fetal rat calvaria cells by retinoic acid (RA) which is known to exert profound effects on skeletal growth and development, bone turnover, and induce specific cellular responses in bone cells. Thus the multiple functions of RA in bone cells are likely to be mediated in part by Ets1. Also, Ets2 transgenic mice develop multiple neurocranial, viserocranial, and cervical skeletal abnormalities. Significantly, these abnormalities are similar to the skeletal anomalies found in trisomy-16 mice and in humans with Down's syndrome, wherein the dosage of Ets2 is known to be increased. These results indicate that Ets2 has an important role in skeletal development and that Ets2 overexpression in transgenics is responsible for the genesis of the same type of skeletal abnormalities that are seen in Down's syndrome. Thus the genetic programs regulated by Ets1 and Ets2 may significantly affect the development and differentiation of osteoblasts, and in fact, Ets1 has been shown to interact with the ‘quintessential’ osteoblast transcription factor CbfA1. This review will examine in detail the role and possible targets of Ets1 and Ets2 in osteoblast differentiation and bone formation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Aperlo C, Pognonec P, Stanley ER and Boulukos KE. . 1996 Mol. Cell. Biol. 16: 6851–6858.

  • Ascione A, Thompson D, Thomas R, Panayiotakis A, Ramsay R, Tymms M, Kola I and Seth A. . 1992 Intl. J. Oncol. 1: 631–637.

  • Aubin JE. . 1998 J. Cell. Biochem. Suppl 31: 73–82.

  • Aubin JE, Liu F, Malaval L and Gupta AK. . 1995 Bone 17: 77S–83S.

  • Bhat NK, Thompson CB, Lindsten T, June CH, Fujiwara S, Koizumi S, Fisher RJ and Papas TS. . 1990 Proc. Natl. Acad. Sci. USA 87: 3723–3727.

  • Chen Z, Fisher RJ, Riggs CW, Rhim JS and Lautenberger JA. . 1997 Cancer Res. 57: 2013–2019.

  • Choi JY, Lee BH, Song KB, Park RW, Kim IS, Sohn KY, Jo JS and Ryoo HM. . 1996 J. Cell. Biochem. 61: 609–618.

  • Dalton S and Treisman R. . 1992 Cell 68: 597–612.

  • Dhordain P, Dewitte F, Desbiens X, Stehelin D and Duterque-Coquillaud M. . 1995 Mech. Dev. 50: 17–28.

  • Ducy P, Zhang R, Geoffroy V, Ridall AL and Karsenty G. . 1997 Cell 89: 747–754.

  • Ducy P, Schinke T, Karsenty G 2000 Science 289: 1501–1504.

  • Fang MA, Noguchi GM and McDougall S. . 1995 Calcif. Tissue Int. 57: 450–455.

  • Frick KK, Jiang L and Bushinsky DA. . 1997 Am. J. Physiol. 272: C1450–C1456.

  • Gilles F, Raes MB, Stehelin D, Vandenbunder B and Fafeur V. . 1996 Exp. Cell. Res. 222: 370–378.

  • Graves BJ and Petersen JM. . 1998 Adv. Cancer. Res. 75: 1–55.

  • Harada H, Miki R, Masushige S and Kato S. . 1995 Endocrinology 136: 5329–5335.

  • Hodge DR, Robinson L, Watson D, Lautenberger J, Zhang XK, Venanzoni M and Seth A. . 1996 Oncogene 12: 11–18.

  • Iseki S, Osumi-Yamashita N, Miyazono K, Franzen P, Ichijo H, Ohtani H, Hayashi Y and Eto K. . 1995 Exp. Cell. Res. 219: 339–347.

  • Iwamoto M, Higuchi Y, Koyama E, Enomoto-Iwamoto M, Kurisu K, Yeh H, Abrams WR, Rosenbloom J and Pacifici M. . 2000 J. Cell. Biol. 150: 27–40.

  • Janknecht R and Nordheim A. . 1993 Biochim. Biophys. Acta. 1155: 346–356.

  • Karperien M, Farih-Sips H, Lowik CW, de Laat SW, Boonstra J and Defize LH. . 1997 Mol. Endocrinol. 11: 1435–1448.

  • Kodama H, Amagai Y, Sudo H, Kasai S and Yamamoto S. . 1981 Japan. J. Oral Biol. 23: 899–901.

  • Kola I, Brookes S, Green AR, Garber R, Tymms M, Papas TS and Seth A. . 1993 Proc. Natl. Acad. Sci. USA 90: 7588–7592.

  • Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S and Kishimoto T. . 1997 Cell 89: 755–764.

  • Kurihara N, Ishizuka S, Kiyoki M, Haketa Y, Ikeda K and Kumegawa M. . 1986 Endocrinology 118: 940–947.

  • Leid M, Kastner P and Chambon P. . 1992 Trends Biochem. Sci. 17: 427–433.

  • Li R, Pei H and Papas T. . 1999 Proc. Natl. Acad. Sci. USA 96: 3876–3881.

  • Linney E. . 1992 Curr. Top. Dev. Biol. 27: 309–350.

  • Mackie EJ and Ramsey S. . 1996 J. Cell. Sci. 109: 1597–1604.

  • Mackie EJ and Tucker RP. . 1992 J. Cell. Sci. 103: 765–771.

  • Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A and Evans RM. . 1992 Genes Dev. 6: 329–344.

  • Maroulakou IG, Papas TS and Green JE. . 1994 Oncogene 9: 1551–1565.

  • McKee MD and Nanci A. . 1996a Microsc. Res. Tech. 33: 141–164.

  • McKee MD and Nanci A. . 1996b Connect. Tissue Res. 35: 197–205.

  • McMahon AP, Champion JE, McMahon JA and Sukhatme VP. . 1990 Development 108: 281–287.

  • Mulkins MA, Manolagas SC, Deftos LJ and Sussman HH. . 1983 J. Biol. Chem. 258: 6219–6225.

  • Nakayama Y, Takahashi K, Noji S, Muto K, Nishijima K and Taniguchi S. . 1990 FEBS Lett. 261: 93–96.

  • Ng KW, Gummer PR, Michelangeli VP, Bateman JF, Mascara T, Cole WG and Martin TJ. . 1988 J. Bone Miner. Res. 3: 53–61.

  • Ohishi K, Ishida H, Nagata T, Yamauchi N, Tsurumi C, Nishikawa S and Wakano Y. . 1994 J. Cell. Physiol. 161: 544–552.

  • Quarles LD, Yohay DA, Lever LW, Caton R and Wenstrup RJ. . 1992 J. Bone Miner. Res. 7: 683–692.

  • Raouf A, Li V, Kola I, Watson DK and Seth A. . 2000 Oncogene 19: 1969–1974.

  • Robinson L, Panayiotakis A, Papas TS, Kola I and Seth A. . 1997 Proc. Natl. Acad. Sci. USA 94: 7170–7175.

  • Sato M, Morii E, Komori T, Kawahata H, Sugimoto M, Terai K, Shimizu H, Yasui T, Ogihara H, Yasui N, Ochi T, Kitamura Y, Ito Y and Nomura S. . 1998 Oncogene 17: 1517–1525.

  • Sato Y. . 1998 Hum. Cell. 11: 207–214.

  • Seth A and Papas TS. . 1990 Oncogene 5: 1761–1767.

  • Seth A, Ascione R, Fisher RJ, Mavrothalassitis GJ, Bhat NK and Papas TS. . 1992 Cell Growth Differ. 3: 327–334.

  • Seth A, Lee BK, Qi S and Vary CP. . 2000 J. Bone Miner. Res. 15: 1683–1696.

  • Seth A, Robinson L, Panayiotakis A, Thompson DM, Hodge DR, Zhang XK, Watson DK, Ozato K and Papas TS. . 1994 Oncogene 9: 469–477.

  • Seth A, Robinson L, Thompson DM, Watson DK and Papas TS. . 1993 Oncogene 8: 1783–1790.

  • Seth A, Watson DK, Blair DG and Papas TS. . 1989 Proc. Natl. Acad. Sci. USA 86: 7833–7837.

  • Sevilla L, Aperlo C, Dulic V, Chambard JC, Boutonnet C, Pasquier O, Pognonec P and Boulukos KE. . 1999 Mol. Cell. Biol. 19: 2624–2634.

  • Shirasaki F, Makhluf HA, LeRoy C, Watson DK and Trojanowska M. . 1999 Oncogene 18: 7755–7764.

  • Stein GS and Lian JB. . 1993 Endocr Rev. 14: 424–442.

  • Sudo H, Kodama HA, Amagai Y, Yamamoto S and Kasai S. . 1983 J. Cell. Biol. 96: 191–198.

  • Sumarsono SH, Wilson TJ, Tymms MJ, Venter DJ, Corrick CM, Kola R, Lahoud MH, Papas TS, Seth A and Kola I. . 1996 Nature 379: 534–537.

  • Takeuchi Y, Fukumoto S and Matsumoto T. . 1995 J. Cell. Physiol. 162: 315–321.

  • Topol LZ, Tatosyan AG, Ascione R, Thompson DM, Blair DG, Kola I and Seth A. . 1992 Cancer Lett. 67: 71–78.

  • Traianedes K, Ng KW, Martin TJ and Findlay DM. . 1993 J. Cell. Physiol. 157: 243–252.

  • Varga F, Rumpler M, Luegmayr E, Fratzl-Zelman N, Glantschnig H and Klaushofer K. . 1997 Calcif. Tissue Int. 61: 404–411.

  • Vary CP, Li V, Raouf A, Kitching R, Kola I, Franceschi C, Venanzoni M and Seth A. . 2000 Exp. Cell. Res. 257: 213–222.

  • Venanzoni MC, Robinson LR, Hodge DR, Kola I and Seth A. . 1996 Oncogene 12: 1199–1204.

  • Walunas TL, Wang B, Wang CR and Leiden JM. . 2000 J. Immunol. 164: 2857–2860.

  • Wang DY, Yang VC and Chen JK. . 1997 In Vitro Cell Dev. Biol. Anim. 33: 248–255.

  • Wasylyk B, Hagman J and Gutierrez-Hartmann A. . 1998 Trends Biochem. Sci. 23: 213–216.

  • Watson DK, Robinson L, Hodge DR, Kola I, Papas TS and Seth A. . 1997 Oncogene 14: 213–221.

  • Yang SH, Yates PR, Whitmarsh AJ, Davis RJ and Sharrocks AD. . 1998 Mol. Cell. Biol. 18: 710–220.

  • Zhou H, Hammonds Jr RG, Findlay DM, Fuller PJ, Martin TJ and Ng KW. . 1991 J. Bone Miner. Res. 6: 767–777.

Download references

Acknowledgements

This article is dedicated to Dr Takas S Papas, a close friend and colleague. We would like to thank Vincent Li for technical assistance and Drs J Aubin for discussion, and B Ganss, and GA Candeliere for the critical review of this manuscript. This work was supported by a grant (MOP37784) from CIHR to A Seth.

Author information

Authors and Affiliations

  1. Department of Laboratory Medicine and Pathobiology, MRC group in Periodontal Physiology, University of Toronto, Toronto, Canada

    Afshin Raouf & Arun Seth

  2. Laboratory of Molecular Pathology, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada

    Arun Seth

Authors
  1. Afshin Raouf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arun Seth
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raouf, A., Seth, A. Ets transcription factors and targets in osteogenesis. Oncogene 19, 6455–6463 (2000). https://doi.org/10.1038/sj.onc.1204037

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204037

Keywords

This article is cited by

Search

Advanced search

Quick links